These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Adverse events following immunisation associated with the 1998 Australian Measles Control Campaign. D'Souza RM, Campbell-Lloyd S, Isaacs D, Gold M, Burgess M, Turnbull F, O'Brien E. Commun Dis Intell; 2000 Feb 17; 24(2):27-33. PubMed ID: 10758692 [Abstract] [Full Text] [Related]
3. Nationwide campaign for vaccination of adults against rubella and measles--Costa Rica, 2001. Centers for Disease Control and Prevention (CDC). MMWR Morb Mortal Wkly Rep; 2001 Nov 09; 50(44):976-9. PubMed ID: 11724151 [Abstract] [Full Text] [Related]
4. Measles-rubella mass immunization campaign in Albania, November 2000. Bino S, Kakarriqi E, Xibinaku M, Ion-Nedelcu N, Bukli M, Emiroglu N, Uzicanin A. J Infect Dis; 2003 May 15; 187 Suppl 1():S223-9. PubMed ID: 12721917 [Abstract] [Full Text] [Related]
5. Progress in measles and rubella elimination in Iran. Esteghamati A, Gouya MM, Zahraei SM, Dadras MN, Rashidi A, Mahoney F. Pediatr Infect Dis J; 2007 Dec 15; 26(12):1137-41. PubMed ID: 18043452 [Abstract] [Full Text] [Related]
6. A measles and rubella (MR) catch-up vaccination campaign in an Egyptian University: vaccine uptake and knowledge and attitudes of students. Abd Elaziz KM, Sabbour SM, Dewedar SA. Vaccine; 2010 Nov 03; 28(47):7563-8. PubMed ID: 20797454 [Abstract] [Full Text] [Related]
7. The elimination of indigenous measles, mumps, and rubella from Finland by a 12-year, two-dose vaccination program. Peltola H, Heinonen OP, Valle M, Paunio M, Virtanen M, Karanko V, Cantell K. N Engl J Med; 1994 Nov 24; 331(21):1397-402. PubMed ID: 7969278 [Abstract] [Full Text] [Related]
8. The measles/rubella immunisation campaign in Scotland. Skinner R, Christie P, Cowden JM. Health Bull (Edinb); 1996 Jan 24; 54(1):88-98. PubMed ID: 8820234 [Abstract] [Full Text] [Related]
11. Progress toward measles elimination in Romania after a mass vaccination campaign and implementation of enhanced measles surveillance. Pistol A, Hennessey K, Pitigoi D, Ion-Nedelcu N, Lupulescu E, Walls L, Bellini W, Strebel P. J Infect Dis; 2003 May 15; 187 Suppl 1():S217-22. PubMed ID: 12721916 [Abstract] [Full Text] [Related]
15. [Certain problems with limits of immunity against measles, mumps and rubella]. Magdzik W. Przegl Epidemiol; 1993 May 15; 47(1-2):47-53. PubMed ID: 8351387 [Abstract] [Full Text] [Related]
16. The use of rapid coverage monitoring in the national rubella vaccination campaign, Haiti 2007-2008. Lacapère F, Magloire R, Danovaro-Holliday MC, Flannery B, Chamoulliet H, Celestin EP. J Infect Dis; 2011 Sep 01; 204 Suppl 2():S698-705. PubMed ID: 21954269 [Abstract] [Full Text] [Related]
17. The Measles Control Campaign and immunisation adverse events. Burgess MA, Heath TC, McIntyre PB. Commun Dis Intell; 1998 Jul 09; 22(7):136-8. PubMed ID: 9684532 [No Abstract] [Full Text] [Related]
18. Progress in Italy in control and elimination of measles and congenital rubella. Bonanni P, Bechini A, Boccalini S, Peruzzi M, Tiscione E, Boncompagni G, Mannelli F, Salmaso S, Filia A, Ciofi degli Atti M. Vaccine; 2007 Apr 20; 25(16):3105-10. PubMed ID: 17306425 [Abstract] [Full Text] [Related]
19. Efficacy of measles and rubella vaccination one year after the nationwide campaign in Shiraz, Iran. Pourabbas B, Ziyaeyan M, Alborzi A, Mardaneh J. Int J Infect Dis; 2008 Jan 20; 12(1):43-6. PubMed ID: 17950020 [Abstract] [Full Text] [Related]
20. Supplementary immunization activities to achieve measles elimination: experience of the European Region. Khetsuriani N, Deshevoi S, Goel A, Spika J, Martin R, Emiroglu N. J Infect Dis; 2011 Jul 20; 204 Suppl 1():S343-52. PubMed ID: 21666183 [Abstract] [Full Text] [Related] Page: [Next] [New Search]